SRx Health Solutions Inc. (SRXH)

Revenue by Segment

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023
Consumer Products	6.53M	-	-
Pharmacy and Sale of Prescription Drugs	-	-	118.38M
Clinical Trials	-	-	1.04M
Total	6.53M	-	119.42M

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022
United States	5.51M	-	-	-
Canada	-	-	119.42M	93.18M
Canada Growth	-	-	28.16%	-
Taiwan	833.00K	-	-	-
Other	196.00K	-	-	-
Total	6.53M	-	119.42M	93.18M
Total Growth	-	-	28.16%	-

Source: S&P Global Market Intelligence.